World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
103
Citations
40300
World Ranking
7344
National Ranking
3844

Douglas A. Jabs publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Douglas A. Jabs sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 475 publications — 54th percentile

54% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Douglas A. Jabs D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Douglas A. Jabs sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 103 D-Index — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Douglas A. Jabs is affiliated with Johns Hopkins University School of Medicine in the United States. Their research is primarily situated within the field of Medicine, with a significant focus on Ophthalmology. The scope of their work also encompasses related subfields including Rheumatology, Infectious Diseases, Epidemiology, and Pulmonary and Respiratory Medicine.

Their publications cover a range of topics, particularly:

  • Ocular Diseases and Behçet's Syndrome
  • Retinal and Optic Conditions
  • Retinal Diseases and Treatments
  • Systemic Lupus Erythematosus Research
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • Vasculitis and related conditions

Douglas A. Jabs has contributed to several recent papers, including:

  • Early Outpatient Treatment for Covid-19 with Convalescent Plasma (2022), published in New England Journal of Medicine
  • Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis-Report 1 (2020), published in Ophthalmology
  • Uveitis for the non-ophthalmologist (2021), published in BMJ
  • Risk of Cataract Development among Children with Juvenile Idiopathic Arthritis-Related Uveitis Treated with Topical Corticosteroids (2020), published in Ophthalmology
  • Seven-Year Outcomes of Uveitic Macular Edema: The Multicenter Uveitis Steroid Treatment Trial and Follow-up Study Results (2020), published in Ophthalmology

Their frequent coauthors include:

  • Jennifer E. Thorne
  • John H. Kempen
  • Sapna Gangaputra
  • James T. Rosenbaum
  • Eric B. Suhler

Among the venues where they have published regularly are:

  • American Journal of Ophthalmology
  • Ophthalmology
  • Ocular Immunology and Inflammation
  • bioRxiv (Cold Spring Harbor Laboratory)
  • JAMA Ophthalmology

Best Publications

  • Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop.

    Douglas A Jabs;Robert B Nussenblatt;James T Rosenbaum

  • Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia

    GJ Anhalt;SC Kim;JR Stanley;NJ Korman

  • Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel

    Douglas A. Jabs;James T. Rosenbaum;C.Stephen Foster;Gary N. Holland

  • Guidelines for preventing opportunistic infections among HIV-infected persons - 2002

    Henry Masur;Jonathan E. Kaplan;King K. Holmes;Beverly Alston

  • Gut Epithelial Barrier Dysfunction and Innate Immune Activation Predict Mortality in Treated HIV Infection

    Peter W. Hunt;Elizabeth Sinclair;Benigno Rodriguez;Carey Shive

  • Thalidomide for the treatment of chronic graft-versus-host disease.

    G B Vogelsang;E R Farmer;A D Hess;V Altamonte

  • Cytomegalovirus retinitis and acquired immunodeficiency syndrome.

    Douglas A. Jabs;Cheryl Enger;John G. Bartlett

  • Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders.

    Grace Levy-Clarke;Douglas A. Jabs;Russell W. Read;James T. Rosenbaum

  • Ocular Involvement in Chronic Sarcoidosis

    Douglas A. Jabs;Carol J. Johns

  • Episcleritis and scleritis: clinical features and treatment results.

    Douglas A. Jabs;Abdulbaki Mudun;J.P. Dunn;Marta J. Marsh

  • Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease.

    Justine R. Smith;Ralph D. Levinson;Gary N. Holland;Douglas A. Jabs

  • Ocular manifestations of HIV infection.

    DA Jabs

  • Randomized Comparison of Systemic Anti-inflammatory Therapy Versus Fluocinolone Acetonide Implant for Intermediate, Posterior, and Panuveitis: The Multicenter Uveitis Steroid Treatment Trial

    John H. Kempen;Michael M. Altaweel;Janet T. Holbrook;Douglas A. Jabs

  • Ocular Manifestations of Acquired Immune Deficiency Syndrome

    Douglas A. Jabs;W. Richard Green;Robin Fox;B. Frank Polk

  • Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis

    R. A. Lewis;P. Clogston;Victor Fainstein;R. Gross

  • Methotrexate for Ocular Inflammatory Diseases

    Sapna Gangaputra;Sapna Gangaputra;Craig W. Newcomb;Teresa L. Liesegang;R. Oktay Kaçmaz

  • Azathioprine for Ocular Inflammatory Diseases

    Sirichai Pasadhika;John H. Kempen;Craig W. Newcomb;Teresa L. Liesegang

  • Decrease in the risk of bilateral acute retinal necrosis by acyclovir therapy.

    David A. Palay;Paul Sternberg;Janet Davis;Hilel Lewis

  • Cyclosporine for Ocular Inflammatory Diseases

    R. Oktay Kaçmaz;John H. Kempen;Craig Newcomb;Ebenezer Daniel;Ebenezer Daniel

  • Methotrexate for Ocular Inflammatory Diseases

    G. A. Levy-Clarke;S. Gangaputra;C. W. Newcomb;D. A. Jabs

Frequent Co-Authors

Jennifer E. Thorne
Jennifer E. Thorne Johns Hopkins University
James T. Rosenbaum
James T. Rosenbaum Oregon Health & Science University
Robert B. Nussenblatt
Robert B. Nussenblatt National Institutes of Health
C. Stephen Foster
C. Stephen Foster Harvard University
Gary N. Holland
Gary N. Holland University of California, Los Angeles
Susan Lightman
Susan Lightman University College London
Mark A. Jacobson
Mark A. Jacobson University of California, San Francisco
Janet L. Davis
Janet L. Davis University of Miami
Grant James Anhalt
Grant James Anhalt Johns Hopkins University
Robert L. Murphy
Robert L. Murphy Northwestern University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in medical careers but seeking flexible or alternative paths, there are several related online degrees worth considering. A health administration degree is an excellent option for those interested in the business and management side of healthcare. This degree can prepare graduates for roles in hospital administration, health services management, and more.

Many working professionals opt for a master's degree to advance their career. The most affordable online mha programs offer accessible pathways for those looking to step into leadership roles within healthcare organizations without putting their career on hold.

For nurses aiming to reach the pinnacle of clinical practice, the cheapest dnp online programs provide doctoral-level education in nursing practice. These programs help nurses gain skills for advanced practice roles, leadership, and clinical research.

Aspiring pharmacists can explore the option of an online pharmacist degree. This flexible degree path prepares graduates for licensure and practice in pharmacy, with many programs designed to accommodate working students.

Best Scientists Citing Douglas A. Jabs

Trending Scientists

Recently Published Articles